As One Corp
TSE:7476
As One Corp
TSE:7476
Price:
2 593.5 JPY
2.96%
Updated:
Apr 29, 2024
EV/FCFF
Enterprise Value to FCFF
Enterprise Value to FCFF
25.4
Current
43.7
Median
19.7
Industry
Lower
than median
Higher
than industry value
Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.
EV/FCFF
=25.4
Enterprise Value
/
176.3B
FCFF
7B
All Countries
| Market Cap | EV/FCFF | ||||
|---|---|---|---|---|---|
| JP |
|
As One Corp
TSE:7476
|
187.8B JPY | 25.4 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
71.2B USD | 25.9 | |
| US |
|
Cencora Inc
NYSE:COR
|
48B USD | 13.6 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 13.7 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
25.2B USD | 7.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.5B USD | 36.7 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | -285 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63B HKD | 4.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
57.7B CNY | 28.7 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.1B EUR | 29.7 | |
| CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51.4B CNY | 31.4 |
EV/FCFF Forward Multiples
Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A
You don't have any saved screeners yet
